Bridget A. Finniff
ORCID：0009-0004-9331-9535
发表论文 49 篇 · 总被引 26 次 · h-index 3
代表论文
- Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers (2025 · Science Signaling · 被引 4)
- SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer (2025 · Science Signaling · 被引 3)
- Figure S8 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S4 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S18 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)
- Figure S2 from SOS1 Inhibition Enhances the Efficacy of KRAS<sup>G12C</sup> Inhibitors and Delays Resistance in Lung Adenocarcinoma (2026)